D6.1 Vendor Specific AI Models

D6.1 Vendor Specific AI Models

Deliverable 6.1, led by partner RADBOUDUMC, titled ”Development of Vendor-Specific AI Models,” describes the work performed in Tasks 6.1, 6.2, and 6.3 in WP6. Task 6.1 describes the ”Prospective dataupload to the platform” (Leader: RADBOUDUMC, Participants: FPO,...

read more
D5.3 Deep Learning Master model and Radiomic Signatures

D5.3 Deep Learning Master model and Radiomic Signatures

Deliverable 5.3, led by partner FCHAMPALIMAUD, contains the work performed by the ProCAncer-Iconsortium on master models using radiomics and deep learning techniques. ’Master models’ — modelswhich can act as a foundation for other models — were developed for radiomics...

read more
D3.6 Final Data Management Plan

D3.6 Final Data Management Plan

This deliverable based on the DoW entitled “Final Data Management Plan (DMP)” is an updatedversion of the Pro-CAncer-I project’s DMP (D3.5), in accordance with the regulations of the Pilotaction on Open Access to Research Data of the Horizon 2020 program (H2020). It...

read more
D3.3 2nd Dissemination and Communication Activities

D3.3 2nd Dissemination and Communication Activities

The deliverable (D3.3) describes all Communication and Dissemination activities that have takenplace during the period 1/4/2022-30/9/2023. Scope of the activities is to maximize the impactand the awareness of the project. All tasks have involved the whole consortium...

read more
D5.1 Retrospective Data Retrieval and upload

D5.1 Retrospective Data Retrieval and upload

This deliverable describes the process performed to retrieve Retrospective Data and upload themto the ProCAncer-I platform, as it is defined in the relevant task 5.1 of the DoA. In more detail,the task 5.1 states that Retrospective examinations that fulfill inclusion...

read more
D5.2 Pre-processing tools

D5.2 Pre-processing tools

ProCAncer-I aims to develop novel AI models in order to add precision in the management ofprostate cancer patients by providing diagnostic tools able to reduce overdiagnosis andovertreatment. To this end, a unique dataset from the project's clinical sites is being...

read more
D3.7 Open Research Data Pilot

D3.7 Open Research Data Pilot

D3.7 “Open Research Data Pilot” of the project ProCAncer-I is prepared under the activities of WP3 - Dissemination, Communication, Open data availability and Data management Plan. In line with the principles of Open Access to Research Data, ProCAncer-I will provide...

read more
D3.2 1st Dissemination and Communication Activities Report

D3.2 1st Dissemination and Communication Activities Report

The deliverable describes all Communication and Dissemination activities that have taken place since the beginning of the project, and mainly after the submission of the Communication Roadmap. Scope of the activities is to maximize the impact and the awareness of the...

read more
D3.5 Initial Data Management Plan

D3.5 Initial Data Management Plan

This deliverable is the initial version of the Data Management Plan (DMP) of the ProCancer-I project, in accordance to the regulations of the Pilot action on Open Access to Research Data of the Horizon 2020 program (H2020). It contains provisional information about...

read more

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!